The daily number of new coronavirus infections in Germany remains high but the country’s partial lockdown is having a positive effect, the head of the Robert Koch Institute disease control center said on Thursday.
For more coronavirus news, visit our dedicated page.
“The situation ... is still serious, very serious,” Lothar Wieler told a press conference.
Read more: Germany should brace for 4-5 months of severe coronavirus measures: Minister
“The number of cases has stabilized at a high level in the last two weeks and is not rising any further” but is “still very high, much too high,” he said, adding he was “optimistic” that the numbers would soon start to fall again.
For all the latest headlines follow our Google News channel online or via the app
Coronavirus: Germany reports 14,419 new COVID-19 casesThe number of confirmed coronavirus cases in Germany increased by 14,419 to 815,746, data from the Robert Koch Institute (RKI) for infectious diseases ... Coronavirus
Germany should brace for 4-5 months of severe coronavirus measures: MinisterGermans should brace for another 4-5 months of severe measures to halt the rise in coronavirus infections and should not expect the current rules to ... Coronavirus
Germany plans $26 bln in coronavirus aid for companies in first half of 2021Germany expects to pay out 22 billion euros ($26 billion) in COVID-19 relief aid from January through June 2021 to companies and self-employed people, ... Coronavirus
Germany sees signs of coronavirus infections easingGermany is seeing tentative signs that a surge in coronavirus infections may be easing, the head of the country’s disease control agency RKI said on ... Coronavirus
Germany launches four-week partial shutdown to flatten rise in coronavirus casesA four-week partial shutdown has started in Germany, with restaurants, bars, theaters, cinemas and other leisure facilities closing down until the end ... Coronavirus
Coronavirus: Germany’s Curevac says vaccine produced antibodies in volunteersCureVac’s experimental COVID-19 vaccine triggered an immune response in humans, the German biotech firm said on Monday, putting it on track to start ... Coronavirus